ArticleFrontiers in pharmacology2025
Case Report: Third-degree atrioventricular block and respiratory failure caused by clozapine poisoning.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Case of Clozapine Toxicity Caused by Infection in a Patient with Treatment-Resistant Schizophrenia.International medical case reports journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This case report details the management of a patient who presented with third-degree atrioventricular block and rhabdomyolysis secondary to clozapine intoxication. Case summary: The patient was a 55-year-old man who took 100 tablets of clozapine and was transferred to our hospital from a lower-level hospital for treatment. Upon arrival at our hospital, he was in a coma and was assisted with mechanical ventilation. Upon admission, based on the results of toxicological tests and laboratory examination; computed tomography, magnetic resonance imaging, and echocardiography findings, and the patient's clinical manifestations, the diagnosis of third-degree atrioventricular block and rhabdomyolysis due to excessive intake of clozapine was confirmed. The patient received comprehensive treatment, including blood purification, organ protection, nutritional support, and cardiac rate enhancement. The patient was clinically cured and discharged. Clozapine-induced central nervous system inhibition can be dose-dependent, thus leading to coma and organ damage at high doses. Considering that no specific antidotes are available, cases involving clozapine toxicity require careful management. In this instance, beyond the central nervous system and respiratory depression, the patient also exhibited third-degree atrioventricular block and rhabdomyolysis, which warrant significant attention. Conclusion: Many patients with clozapine poisoning have been admitted to our department. Clozapine poisoning mostly causes symptoms such as accelerated heart rate, but in our patient's case, third-degree atrioventricular block and rhabdomyolysis symptoms occurred unusually. For clozapine poisoning, timely and appropriate management is crucial for the recovery of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.